203 related articles for article (PubMed ID: 24673083)
1. Pharmacovigilance in Qatar: a survey of pharmacists.
Wilbur K
East Mediterr Health J; 2013 Nov; 19(11):930-5. PubMed ID: 24673083
[TBL] [Abstract][Full Text] [Related]
2. Hospital pharmacists' knowledge and opinions regarding adverse drug reaction reporting in Northern China.
Su C; Ji H; Su Y
Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):217-22. PubMed ID: 20033911
[TBL] [Abstract][Full Text] [Related]
3. Pharmacists' attitudes towards the reporting of suspected adverse drug reactions in Norway.
Granas AG; Buajordet M; Stenberg-Nilsen H; Harg P; Horn AM
Pharmacoepidemiol Drug Saf; 2007 Apr; 16(4):429-34. PubMed ID: 16953518
[TBL] [Abstract][Full Text] [Related]
4. Knowledge about adverse drug reactions reporting among healthcare professionals in Nepal.
Santosh KC; Tragulpiankit P; Edwards IR; Gorsanan S
Int J Risk Saf Med; 2013 Jan; 25(1):1-16. PubMed ID: 23442293
[TBL] [Abstract][Full Text] [Related]
5. Reporting natural health product related adverse drug reactions: is it the pharmacist's responsibility?
Walji R; Boon H; Barnes J; Welsh S; Austin Z; Baker GR
Int J Pharm Pract; 2011 Dec; 19(6):383-91. PubMed ID: 22060233
[TBL] [Abstract][Full Text] [Related]
6. Knowledge, Practice and Attitudes Toward Pharmacovigilance and Adverse Drug Reactions Reporting Process Among Health Care Providers in Dammam, Saudi Arabia.
Ali MD; Hassan YA; Ahmad A; Alaqel O; Al-Harbi H; Al-Suhaimi NM
Curr Drug Saf; 2018; 13(1):21-25. PubMed ID: 29256354
[TBL] [Abstract][Full Text] [Related]
7. The lack of knowledge about the voluntary reporting system of adverse drug reactions as a major cause of underreporting: direct survey among health professionals.
Pérez García M; Figueras A
Pharmacoepidemiol Drug Saf; 2011 Dec; 20(12):1295-302. PubMed ID: 21793098
[TBL] [Abstract][Full Text] [Related]
8. Hospital pharmacists' activities and attitudes regarding the Thai safety monitoring program for new drugs.
Jarernsiripornkul N; Krska J; Pongmanachai M; Nasritha N
Pharmacoepidemiol Drug Saf; 2009 Sep; 18(9):837-41. PubMed ID: 19548223
[TBL] [Abstract][Full Text] [Related]
9. Medication safety knowledge, attitudes and practices among community pharmacists in Lebanon.
Hajj A; Hallit S; Ramia E; Salameh P;
Curr Med Res Opin; 2018 Jan; 34(1):149-156. PubMed ID: 28758813
[TBL] [Abstract][Full Text] [Related]
10. Pharmacovigilance amongst patent medicine vendors (PMVs) in Ekiti state, Nigeria.
Awodele O; Adeniran A; Awodele DF
Int J Risk Saf Med; 2012; 24(2):65-72. PubMed ID: 22751188
[TBL] [Abstract][Full Text] [Related]
11. Knowledge, attitude and practices associated with adverse drug reaction reporting amongst doctors in a teaching hospital.
Chopra D; Wardhan N; Rehan HS
Int J Risk Saf Med; 2011; 23(4):227-32. PubMed ID: 22156087
[TBL] [Abstract][Full Text] [Related]
12. Perception of pharmacovigilance among doctors in a tertiary care hospital: influence of an interventional lecture.
Sanghavi DR; Dhande PP; Pandit VA
Int J Risk Saf Med; 2013; 25(4):197-204. PubMed ID: 24305558
[TBL] [Abstract][Full Text] [Related]
13. Community pharmacists' knowledge and perspectives of reporting adverse drug reactions in Australia: a cross-sectional survey.
Li R; Curtain C; Bereznicki L; Zaidi STR
Int J Clin Pharm; 2018 Aug; 40(4):878-889. PubMed ID: 30097819
[TBL] [Abstract][Full Text] [Related]
14. Adverse drug reactions reporting: pharmacists' knowledge, attitude and practice in Shiraz, Iran.
Afifi S; Maharloui N; Peymani P; Namazi S; Gharaei AG; Jahani P; Lankarani KB
Int J Risk Saf Med; 2014; 26(3):139-45. PubMed ID: 25214159
[TBL] [Abstract][Full Text] [Related]
15. Pharmacovigilance and adverse drug reaction reporting: a perspective of community pharmacists and pharmacy technicians in Sana'a, Yemen.
Al-Worafi YM; Kassab YW; Alseragi WM; Almutairi MS; Ahmed A; Ming LC; Alkhoshaiban AS; Hadi MA
Ther Clin Risk Manag; 2017; 13():1175-1181. PubMed ID: 28924350
[TBL] [Abstract][Full Text] [Related]
16. The role of hospital and community pharmacists in pharmacovigilance.
van Grootheest AC; de Jong-van den Berg LT
Res Social Adm Pharm; 2005 Mar; 1(1):126-33. PubMed ID: 17138470
[TBL] [Abstract][Full Text] [Related]
17. A national survey of knowledge, attitude, practice, and barriers towards pharmacovigilance and adverse drug reaction reporting among hospital pharmacy practitioners in the United Arab Emirates.
Shanableh S; Zainal H; Alomar M; Palaian S
J Pharm Policy Pract; 2023 Jul; 16(1):92. PubMed ID: 37464445
[TBL] [Abstract][Full Text] [Related]
18. Adverse drug reaction reporting by general medical practitioners and retail pharmacists in Harare--a pilot study.
Ball D; Tisócki T
Cent Afr J Med; 1998 Aug; 44(8):190-5. PubMed ID: 10101417
[TBL] [Abstract][Full Text] [Related]
19. Knowledge of Adverse Drug Reaction Reporting Among Healthcare Professionals in Bhutan: A Cross-Sectional Survey.
Dorji C; Tragulpiankit P; Riewpaiboon A; Tobgay T
Drug Saf; 2016 Dec; 39(12):1239-1250. PubMed ID: 27743333
[TBL] [Abstract][Full Text] [Related]
20. The knowledge and attitude of the Turkish community pharmacists toward pharmacovigilance in the Kadikoy district of Istanbul.
Toklu HZ; Uysal MK
Pharm World Sci; 2008 Oct; 30(5):556-62. PubMed ID: 18350373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
